GlassScriptPhysician profile
Arturo E Palencia
NPI 1104890151
$14,257.89
in general payments reported to CMS, 2019-2025
31 companies · $1,475 in 2025
The $1,475 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,990 · 2020: $1,956 · 2021: $1,220 · 2022: $2,833 · 2023: $1,545 · 2024: $1,239 · 2025: $1,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,258.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,557.21 | 2019-2025 | General - Pain Management, General - Therapies, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $2,881.59 | 2019-2024 | Senza |
| Vertiflex, INC. | $2,023.57 | 2019 | |
| Spinal Simplicity, LLC | $1,240.53 | 2022 | |
| Collegium Pharmaceutical, INC. | $1,200.63 | 2019-2025 | Xtampza, Belbuca |
| Painteq LLC | $627.48 | 2022-2024 | Painteq |
| Globus Medical, INC. | $602.25 | 2025 | Vyrsa V1, Senza, Omnia |
| Medtronic, INC. | $504.68 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Flowonix Medical Incorporated | $356.65 | 2019 | |
| Scilex Pharmaceuticals INC. | $247.87 | 2020-2024 | Ztlido |
| Biodelivery Sciences International, INC. | $242.24 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.21 | 2019-2025 | Relistor |
| Medtronic USA, INC. | $97.27 | 2019-2020 | |
| Stratus Medical, LLC | $69.23 | 2022 | |
| Avanos Medical | $60.62 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $59.17 | 2019 | |
| Pfizer INC. | $41.83 | 2019 | |
| Si-Bone, INC. | $39.07 | 2021-2022 | |
| Abbott Laboratories | $33.94 | 2022 | |
| Relievant Medsystems, INC. | $31.97 | 2021 | |
| Protega Pharmaceutials INC | $29.23 | 2025 | Roxybond |
| Zyla Life Sciences, INC. | $27.82 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.75 | 2025 | |
| Grt US Holding, INC. | $20.76 | 2020 | |
| Depuy Synthes Sales INC. | $20.10 | 2020 | |
| Tersera Therapeutics LLC | $17.96 | 2019 | |
| Redhill Biopharma INC. | $17.68 | 2020 | |
| Mdd US Operations, LLC | $15.42 | 2020 | |
| Merit Medical Systems INC | $14.12 | 2022 | |
| Lilly USA, LLC | $12.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Palencia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.